Veterinary Cardiology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type (Companion Animals, Production Animals), By Product (Pharmaceuticals, Diagnostics), By Indication (Congestive Heart Failure, Myocardial Disease, Arrythmias, Others), By End Use (Veterinary Hospitals & Clinics, Others), By Region & Competition, 2019-2029F

Market Overview

Global Veterinary Cardiology Market was valued at USD 2.32 billion in 2023 and is expected to reach USD 3.75 billion by 2029 with a CAGR of 8.31% during the forecast period. The veterinary cardiology market is growing due to increased awareness of heart diseases in pets and advancements in diagnostic and treatment technologies. Innovations such as advanced imaging techniques and minimally invasive procedures are enhancing the accuracy and effectiveness of cardiac care for animals. This market expansion is driven by rising pet ownership and demand for specialized veterinary services, supported by ongoing research and development in veterinary cardiology.

Key Market Drivers

Increasing Prevalence of Cardiovascular Diseases in Pets

The increasing prevalence of cardiovascular diseases in pets is a major driver behind the growth of the veterinary cardiology market. As pets live longer due to advancements in veterinary medicine, improved nutrition, and enhanced overall care, they become more susceptible to age-related cardiovascular conditions. Cats commonly suffer from hypertension whoever 30 percent of cats over twelve years old are affected by this disease, among humans the overall prevalence globally ranges between 35 percent and 45 percent. Among dogs, Myxomatous Mitral Valve Disease (MMVD) is the leading cardiac problem, affecting almost 10 percent of dogs. This trend mirrors broader patterns seen in human healthcare, where longer lifespans correlate with higher incidences of chronic diseases. Moreover, conditions such as congestive heart failure, dilated cardiomyopathy, and mitral valve disease are becoming more common among senior pets. This surge in cardiovascular issues is a direct result of longer lifespans combined with genetic predispositions and lifestyle factors that exacerbate heart health problems. Therefore, there is a growing need for specialized diagnostic and treatment options to manage these complex conditions. Pet owners are increasingly seeking advanced veterinary cardiology services to ensure their pets receive appropriate and timely care, reflecting a shift toward more proactive and comprehensive health management for animals. The rising incidence of these diseases underscores the need for continued innovation and investment in veterinary cardiology, driving market expansion as veterinary practices and specialty clinics respond to the growing demand for expert cardiovascular care.

Advancements in Veterinary Cardiology Technologies and Treatments

Advancements in veterinary cardiology technologies and treatments are pivotal in driving the growth of the market by significantly enhancing the diagnosis, management, and treatment of cardiovascular diseases in pets. The development and refinement of advanced diagnostic tools, such as high-resolution echocardiography, sophisticated electrocardiography systems, and cardiac magnetic resonance imaging (MRI), have revolutionized the ability to detect and monitor heart conditions with greater precision. These technologies provide veterinarians with detailed insights into the structure and function of the heart, enabling more accurate diagnoses and better-informed treatment decisions. In addition to diagnostic advancements, the evolution of minimally invasive surgical techniques, including balloon valvuloplasty, stenting, and catheter-based interventions, has improved treatment outcomes and reduced recovery times for pets undergoing cardiac procedures. Moreover, the introduction of novel therapeutic approaches, such as new pharmacological agents specifically designed for veterinary use and innovative drug delivery systems, has further expanded the arsenal of treatments available for managing cardiovascular diseases. These advancements not only enhance the quality of care for pets but also drive the demand for state-of-the-art veterinary cardiology equipment and services. The continuous innovation in veterinary cardiology technologies and treatments is instrumental in addressing the increasing prevalence of cardiovascular conditions and meeting the growing expectations of pet owners seeking the best possible care for their animals.

Growing Awareness of Preventive Healthcare Among Pet Owners

The growing awareness of preventive healthcare among pet owners is a significant driver of the veterinary cardiology market, reflecting a broader shift toward proactive health management for animals. As pet owners become more educated about the benefits of regular veterinary check-ups and early detection of health issues, they are increasingly prioritizing preventive measures to ensure their pets' well-being. This heightened awareness is fueled by a combination of factors, including increased access to information through digital platforms, social media, and educational campaigns by veterinary organizations. Pet owners are now more informed about the signs of cardiovascular disease and the importance of routine screenings, which has led to a greater emphasis on preventive care strategies, such as regular heart health assessments and early intervention. This proactive approach not only improves the quality of life for pets by catching potential issues before they become severe but also drives demand for specialized veterinary cardiology services. Veterinary practices are responding to this trend by integrating cardiology into their preventive care protocols, offering screenings and early diagnostic services to meet the expectations of informed pet owners. The focus on preventive healthcare represents a fundamental shift in how pet health is managed, contributing to the growth of the veterinary cardiology market as more pet owners seek out advanced diagnostics and treatment options to maintain their animals' cardiovascular health and overall well-being.

Expansion of Veterinary Cardiology Services

The expansion of veterinary cardiology services has been a critical factor driving growth in the veterinary cardiology market, reflecting a broader trend towards specialization and comprehensive care in veterinary medicine. As the prevalence of cardiovascular diseases in pets rises and pet owners increasingly demand high-quality, specialized care, veterinary practices and clinics are integrating cardiology services into their offerings. This expansion includes the establishment of dedicated cardiology departments within general veterinary practices, the development of specialized cardiology clinics, and the creation of referral centers focused exclusively on cardiovascular health. These facilities are equipped with advanced diagnostic tools and staffed by veterinarians with specialized training in cardiology, ensuring that pets receive expert care tailored to their specific needs. The availability of such services facilitates earlier detection and more effective management of cardiovascular conditions, addressing the growing demand for specialized care. Moreover, the proliferation of veterinary cardiology services contributes to a more comprehensive approach to pet health, where cardiology is seamlessly integrated into overall wellness plans. This trend not only improves access to high-quality cardiovascular care but also enhances the ability of veterinary professionals to provide targeted and effective treatments. The expansion of these services underscores the veterinary industry's commitment to addressing the complex needs of pets with cardiovascular issues and reflects a broader shift towards more specialized and preventive health care in the field.

Download Free Sample Report

Key Market Challenges

Limited Availability of Specialized Veterinary Cardiologists

The limited availability of specialized veterinary cardiologists presents a significant challenge to the growth of the veterinary cardiology market. Veterinary cardiology is a highly specialized field that requires extensive training and expertise in diagnosing and treating cardiovascular conditions in animals. However, there is a relative shortage of veterinary cardiologists compared to the increasing demand for such specialized services. This scarcity is partly due to the lengthy and rigorous educational path required to become a board-certified veterinary cardiologist, which includes advanced degrees, clinical experience, and passing specialized certification exams. As a result, there are fewer practitioners who can offer high-level cardiology care, leading to a bottleneck in service availability. This shortage is exacerbated in rural or underserved areas where veterinary specialists are less likely to be present, creating disparities in access to advanced cardiovascular care for pets in these regions.

Moreover, the limited number of specialized veterinary cardiologists also places a strain on existing practitioners, leading to increased workloads and potentially longer wait times for appointments. This situation can hinder timely diagnosis and treatment of cardiovascular diseases, affecting the overall quality of care that pets receive. Veterinary practices that do have cardiology services may experience high demand, resulting in stretched resources and potential burnout among specialists. Addressing this challenge requires efforts to enhance the training pipeline for veterinary cardiologists, increase support for continued professional development, and encourage more veterinarians to enter the field. Additionally, expanding telemedicine options and collaborative care models could help bridge gaps in access and alleviate some of the pressures faced by existing specialists. However, overcoming the shortage of veterinary cardiologists remains a critical challenge for the market and requires coordinated efforts across the veterinary profession to ensure that pets receive the high-quality cardiovascular care they need.

Lack of Standardized Protocols and Guidelines

The lack of standardized protocols and guidelines in veterinary cardiology poses a significant challenge to the market, affecting the consistency and quality of care provided to pets with cardiovascular conditions. Unlike human cardiology, where established guidelines and protocols help ensure uniformity in diagnosis and treatment, the field of veterinary cardiology lacks comprehensive, universally accepted standards. This absence of standardized practices can lead to variations in how cardiovascular diseases are diagnosed and managed across different veterinary practices and regions. Without clear guidelines, there is a risk of inconsistent treatment approaches, which can impact patient outcomes and complicate the decision-making process for veterinarians. This variability can also create confusion for pet owners who seek to understand the best course of action for their pets’ heart health. The development and implementation of standardized protocols are crucial for guiding veterinarians in making evidence-based decisions, ensuring that pets receive appropriate and effective care. Additionally, standardized guidelines would facilitate better training and education for veterinary professionals, contributing to a more uniform level of expertise in cardiology. Efforts to create and disseminate these standards, through collaboration among veterinary organizations and cardiology experts, are essential for improving the overall quality of cardiovascular care in veterinary medicine and addressing the current gaps in care consistency.

Key Market Trends

Increasing Focus on Preventive Cardiology

The increased focus on preventive cardiology in the veterinary field represents a significant shift towards proactive health management for pets, mirroring trends observed in human healthcare. Traditionally, veterinary cardiology largely concentrated on treating cardiovascular diseases once they were diagnosed. However, with growing awareness about the benefits of early intervention, there is now a stronger emphasis on preventive measures to address heart health before issues become severe. This shift is driven by the recognition that early detection of cardiovascular conditions can significantly improve outcomes and quality of life for pets. Veterinary practices are increasingly incorporating routine heart health screenings, diagnostic tests, and lifestyle assessments into their preventive care protocols. Regular check-ups and screenings allow veterinarians to identify risk factors and emerging conditions early, enabling timely intervention and management strategies that can prevent the progression of heart disease.

Furthermore, this focus on preventive cardiology is also supported by advances in veterinary diagnostics and increased pet owner education. Modern diagnostic tools, such as high-resolution echocardiography and continuous cardiac monitoring devices, enable more precise assessments of cardiovascular health, even in asymptomatic pets. Pet owners are becoming more informed about the importance of regular health assessments and are proactively seeking out preventive care services for their animals. This trend reflects a broader societal shift towards preventative health measures and aligns with a growing understanding of the value of maintaining pet health through early detection and intervention. As veterinary practices adapt to this focus, they are not only improving pet health outcomes but also expanding their service offerings to meet the evolving expectations of pet owners, ultimately contributing to the growth of the veterinary cardiology market.

Development of New Pharmacological Therapies

The development of new pharmacological therapies is a transformative trend in the veterinary cardiology market, significantly enhancing treatment options for pets with cardiovascular conditions. Traditionally, the pharmacological management of cardiovascular diseases in animals was limited to a relatively narrow range of drugs, often adapted from human medicine. However, recent advancements in veterinary pharmacology have led to the development of new, pet-specific drugs that offer improved efficacy and safety profiles for managing conditions such as congestive heart failure, arrhythmias, and dilated cardiomyopathy. These novel therapies include innovative formulations of existing drugs, as well as entirely new classes of medications designed specifically for animals. For example, the introduction of new angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and antiarrhythmic agents tailored for veterinary use has expanded the arsenal of tools available to veterinarians, enabling more precise and effective management of cardiovascular diseases.

Moreover, the development of new pharmacological therapies is driven by ongoing research and clinical trials aimed at understanding the unique aspects of cardiovascular disease in animals and addressing unmet needs. Veterinary pharmaceutical companies are investing in research to create drugs that not only improve heart function but also minimize side effects and enhance the overall quality of life for pets. These advancements are accompanied by a growing emphasis on personalized medicine, where treatments are tailored to the individual needs of each pet based on genetic, environmental, and lifestyle factors. As these new therapies become available, they offer the potential for better disease management, prolonged lifespans, and improved quality of life for pets suffering from cardiovascular conditions. This trend reflects a broader commitment to advancing veterinary care and underscores the dynamic nature of the veterinary cardiology market as it evolves to incorporate the latest scientific and therapeutic innovations.

Segmental Insights

Animal Type Insights

Based on the animal type, companion animals are projected to experience rapid growth during the forecast period. The segment's growth is primarily driven by the evolving role of pets, especially dogs, in fulfilling human emotional needs such as companionship and stress relief, combined with heightened awareness and understanding of heart disease in pets among both owners and veterinarians. As pets are increasingly recognized as vital family members, there is a growing demand for specialized care, including cardiology services, to ensure their overall health and longevity. Advancements in veterinary medicine, notably in diagnostic technologies like echocardiography, electrocardiography, radiography, and cardiac catheterization, have allowed for more precise and timely diagnoses of heart conditions in animals. Additionally, the expertise of board-certified cardiologists and ongoing research have significantly improved treatment options and outcomes for pets with cardiovascular diseases.

Download Free Sample Report

Regional Insights

North America emerged as the dominant player in the global Veterinary Cardiology market in 2023. This is due to the growing investment and increasing insurance facilities for advancing animal healthcare. For instance, an article from the North American Pet Health Insurance Association, released in their State of the Industry (SOI) Report in April 2024, highlighted notable expansion in the pet insurance sector during 2023. The report indicated that the industry saw a significant growth of 21.9% over the previous year. Moreover, the region benefits from a highly advanced healthcare infrastructure, including state-of-the-art veterinary clinics and specialty hospitals equipped with cutting-edge cardiology technologies such as high-resolution echocardiography and advanced cardiac MRI. This advanced infrastructure ensures that pets receive top-tier cardiovascular care, driving market growth. Additionally, the high rate of pet ownership and substantial expenditure on pet health and wellness in North America contribute significantly to the market’s expansion. Pet owners in the region are known for their willingness to invest heavily in their animals' health, including specialized services like veterinary cardiology. Additionally, the U.S. pet insurance market has been expanding significantly in recent years. According to the PHI Direct report released in September 2023, approximately 5.36 million pets were insured by their owners out of more than 86.9 million pet-owning households in 2022. Notably, states such as California, New York, and Florida together account for over 30% of all insured pets in the country, underscoring the regional disparities in pet insurance adoption and acceptance across the U.S.

Recent Developments

• In April 2024 - VetPlus launched two new products Gomega and Sustain for Cats. It contains a highly purified dish oil source of omega-3 essential fatty acids that support cardiovascular health and kidney function.
• In October 2023 - Carestream Health announced a new future-focused partnership with EXAMION. The alliance strengthens Carestream’s commitment to providing healthcare organizations in Germany and throughout Europe with innovative diagnostic imaging solutions that help enhance both user and patient experiences while helping to improve clinical outcomes and streamline radiography workflows.
• In September 2023 - The University of Florida College of Veterinary Medicine launched an open-heart surgery program for dogs, becoming the only institution in the U.S. to offer mitral valve repair for canines. This groundbreaking program is led by a skilled veterinary cardiac surgeon who joined UF's faculty in July 2023. The establishment of this program marks a major advancement in veterinary care for dogs with mitral valve disease, providing access to specialized surgical options that were previously rare in the U.S.
• In April 2023 - The Columbus Zoo and Aquarium in Ohio partnered with the Great Ape Heart Project to enhance cardiac care for their great apes. This collaboration aims to improve the understanding and treatment of heart disease in great apes, particularly focusing on gorillas, orangutans, bonobos, and chimpanzees.

Key Market Players

• Boehringer Ingelheim International GmbH
• Jurox Pty Limited
• Ceva Animal Health, LLC
• Merck & Co., Inc.
• IDEXX
• Apex Bio Medicals
• SOUND
• GE HealthCare
• FUJIFILM Holdings America Corporation
• ESAOTE SPA

Report Scope:

In this report, the Global Veterinary Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Veterinary Cardiology Market, By Animal Type:

o   Companion Animals

o   Production Animals

• Veterinary Cardiology Market, By Product:

o   Pharmaceuticals

o   Diagnostics

• Veterinary Cardiology Market, By Indication:

o   Congestive Heart Failure

o   Myocardial Disease

o   Arrythmias

o   Others

• Veterinary Cardiology Market, By End Use:

o   Veterinary Hospitals & Clinics

o   Others

• Veterinary Cardiology Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Egypt

§  Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Veterinary Cardiology Market.

Available Customizations:

Global Veterinary Cardiology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Cardiology Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]